In situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis

Scandinavian Journal of Immunology

Volumn 51, Issue 6, 2000, Pages 548-556

  Mustafa, Tehmina ^a,c   Phyu, S ^a   Nilsen, R ^a   Jonsson, R ^a   Bjune, G ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KINETICS; CYTOKINE RELEASE; IMMUNOHISTOCHEMISTRY; LUNG TUBERCULOSIS; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CHEMOKINE CCL2; CYTOKINES; FEMALE; IMMUNOPHENOTYPING; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; KINETICS; LEUKOCYTES, MONONUCLEAR; LUNG; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034129872     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00721.x     Document Type: Article

References (60)

1. 1 North RJ. Cell mediated immunity and the response to infection. In: McCluskey RT, Cohen S, eds. Mechanisms of Cell-Mediated Immunity. New York: John Wiley & Sons, Inc., 1974: 185-219.
2. 2 Mackaness GB. The immunology of antituberculous immunity. Am Rev Respir Dis 1968;97:337-44.
3. 3 Muller I, Cobbold SP, Waldmann H, Kaufmann SH. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun 1987;55:2037-41.
4. 4 Ladel CH, Daugelat S, Kaufmann SH. Immune response to Mycobacterium bovis bacille Calmette-Guérin infection in major histocompatibility complex class I-and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 1995;25:377-84.
5. 5 Orme IM, Collins FM. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 1984;84:113-20.
6. 6 Stenger S, Modlin RL. Cytotoxic T cell responses to intracellular pathogens. Curr Opin Immunol 1998;10:471-7.
7. 7 Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991;5: 171-7.
8. 8 Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991;12:A49-53.
9. 9 Mosmann TR, Sad S. The expanding universe of T-cell subsets. Th1, Th2 and more. Immunol Today 1996;17:138-46.
10. 10 DiPiro JT. Cytokine networks with infection: Mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 1997;17:205-23.
11. 11 Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-25.
12. 12 Hernandez-Pando R, Orozcoe H, Sampieri A et al. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996;89:26-33.
13. 13 Dlugovitzky D, Torres-Morales A, Rateni L et al. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol 1997;18:203-7.
14. 14 Surcel HM, Troye-Blomberg M, Paulie S et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-6.
15. 15 Baliko Z, Szereday L, Szekeres-Bartho J. Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy. FEMS Immunol Med Microbiol 1998;22:199-204.
16. 16 Sieling PA, Modlin RL. Cytokine patterns at the site of mycobacterial infection. Immunobiology 1994;191:378-87.
17. 17 Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G. A mouse model for slowly progressive primary tuberculosis. Scand J Immunol 1999;50:127-36.
18. 18 Phyu S, Sornes S, Mustafa T, Tadesse A, Jonsson R, Bjune G. Changes in T-lymphocyte subsets in lungs and spleens of mice with slowly progressive primary Mycobacterium tuberculosis infection: Involvement of unconventional T-cell subsets. Scand J Immunol 1999;50:137-44.
19. 19 Pesenti E, Pastore C, Lillo F, Siccardi AG, Vercelli D, Lopalco L. Role of CD4 and CCR5 levels in the susceptibility of primary macrophages to infection by CCR5-dependent HIV type 1 isolates. AIDS Res Hum Retroviruses 1999;15:983-7.
20. 20 Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-22.
21. 21 Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-40.
22. 22 Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
23. 23 Flesch IE, Hess JH, Oswald IP, Kaufmann SH. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: Regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int Immunol 1994;6:693-700.
24. 24 Hernandez-Pando R, Rook GAW. The role of TNF-α in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994;82:591-5.
25. 25 Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996;157:4602-8.
26. 26 Crawford RM, Finbloom DS, Ohara J, Paul WE, Meltzer MS. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J Immunol 1987;139:135-41.
27. 27 Zlotnik A, Fischer M, Roehm N, Zipori D. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: Enhancement of antigen presenting ability of bone marrow-derived macrophages. J Immunol 1987;138:4275-9.
28. 28 Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989;57:503-12.
29. 29 McInnes A, Rennick DM. Interleukin 4 induces cultured monocytes/ macrophages to form giant multinucleated cells. J Exp Med 1988;167:598-611.
30. 30 Flesch IE, Kaufmann SH. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun 1990;58:2675-7.
31. 31 Kikuchi H, Hanazawa S, Takeshita A, Nakada Y, Yamashita Y, Kitano S. Interleukin-4 acts as a potent stimulator for expression of monocyte chemoattractant JE/MCP-1 in mouse peritoneal macrophages. Biochem Biophys Res Commun 1994;203:562-9.
32. 32 Rollins BJ, Pober JS. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 1991;138:1315-9.
33. 33 Kurashima K, Mukaida N, Fujimura M et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 1997;155:1474-7.
34. 34 Lin Y, Gong J, Zhang M, Xue W, Barnes PF. Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun 1998;66:2319-22.
35. 35 Zachariae CO, Anderson AO, Thompson HL et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 1990;171:2177-82.
36. 36 Taub DD, Proost P, Murphy WJ et al. Monocyte chemotactic protein-1 (MCP-1) -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370-6.
37. 37 Johnson CM, Cooper AM, Frank AA, Orme IM. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect Immun 1998;66: 1666-70.
38. 38 Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999;20:307-12.
39. 39 Bermudez LE, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1993;61:3093-7.
40. 40 Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997;158:315-21.
41. 41 de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
42. 42 Pechhold K, Wesch D, Schondelmaier S, Kabelitz D. Primary activation of V gamma 9-expressing gamma delta T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4 T cell help and inhibition by 1L-10. J Immunol 1994;152:4984-92.
43. 43 Gong JH, Zhang M, Modlin RL et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996;64:913-8.
44. 44 Wogensen L, Huang X, Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993;178:175-85.
45. 45 Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in non-obese diabetic mice. J Exp Med 1994;179:1379-84.
46. 46 Moritani M, Yoshimoto K, Tashiro F et al. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 1994;6:1927-36.
47. 47 Giovarelli M, Musiani P, Modesti A et al. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 1995;155:3112-23.
48. 48 Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
49. 49 Phyu S, Tadesse A, Mustafa T, Tadesse S, Jonsson R, Bjune G. Diversity of lung and spleen immune responses in mice with slowly progressive primary tuberculosis. Scand J Immunol 2000;51: 147-54.
50. 50 Marshall BG, Chambers MA, Wangoo A, Shaw RJ, Young DB. Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant. Infect Immun 1997;65:1931-5.
51. 51 Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 1992;182:1155-9.
52. 52 Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
53. 53 Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J Immunol 1998;161:2636-41.
54. 54 Mustafa T, Phyu S, Nilsen R, Bjune G, Jonsson R. Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: A potential novel mechanism of immune evasion by Mycobacterium tuberculosis?. Inflammation 1999;23:507-21.
55. 55 Arai T, Hiromatsu K, Nishimura H et al. Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun 1995;213:600-7.
56. 56 Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994;93:424-8.
57. 57 Filley EA, Rook GAW. Effect of mycobacteria on sensitivity to the cytotoxic effect of tumour necrosis factor. Infect Immun 1991;59:2567-72.
58. 58 Mazzaccaro RJ, Gedde M, Jensen ER et al. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1996;93:11786-91.
59. 59 Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993;90:948-52.
60. - cells that make TH2 cytokines and help B cells. Science 1993;260:1802-5.